Update on Clinical Utilization of Ketamine in Suicide Prevention, Including Psychedelics

Alan F. Schatzberg, MD, Stanford University School of Medicine, presents as part of the 2023 Suicide-Focused Assessment and Treatment: An Update for Professionals course.
Psilocybin and ketamine have been shown to have effects on suicidal ideation. In his talk, Schatzberg discusses how these substances work, their implications in treating suicidality, and current research on the topic.